# Ultrasound-guided Femoral Vein Accessibility, Safety and Time for Atrial Fibrillation Treatment

Study · id `cardio:ct-nct02834221` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02834221](<https://clinicaltrials.gov/study/NCT02834221>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02834221

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 320 participants.

## Technical summary

Registry record NCT02834221. Randomized; single masking; primary purpose prevention. Start 2016-06 (registry gives no type); primary completion 2016-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 320 participants (enrolled count; ClinicalTrials.gov record NCT02834221, source copy `cardio:ctgov-nct02834221-2017-06-07`, retrieved 2026-10-26)
- Start date: 2016-06 (registry gives no type) (ClinicalTrials.gov record NCT02834221, source copy `cardio:ctgov-nct02834221-2017-06-07`, retrieved 2026-10-26)
- Primary completion: 2016-11 (actual) (ClinicalTrials.gov record NCT02834221, source copy `cardio:ctgov-nct02834221-2017-06-07`, retrieved 2026-10-26)
- Completion: 2016-11 (actual) (ClinicalTrials.gov record NCT02834221, source copy `cardio:ctgov-nct02834221-2017-06-07`, retrieved 2026-10-26)
- Countries: Czechia; Japan (ClinicalTrials.gov record NCT02834221, source copy `cardio:ctgov-nct02834221-2017-06-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02834221-2017-06-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Ultrasound-guided Femoral Vein Accessibility, Safety and Time for Atrial Fibrillation Treatment
- Acronym: ULTRA-FAST
- Condition: Atrial Fibrillation
- Condition: Peripheral Vascular Disease
- Condition: Vascular Access Complications
- Intervention (Device): Real-time ultrasound-guided puncture
- Intervention (Other): Anatomical landmark guided puncture
- Lead sponsor: Kenichiro Yamagata
- Lead sponsor class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: Ultrasound-guided versus conventional femoral venipuncture for catheter ablation of atrial fibrillation: a multicentre randomized efficacy and safety trial (ULTRA-FAST trial) (`cardio:pubmed-28575490`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 6992cfb0d256bc8a8550908bc45336cfb33c1d7b3cc51e06ac0c3aa8a5b7f80c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
